Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: February 2020
Date of Filing: February 21, 2020
Principal Executive Offices: Else-Kröner Strasse 1, 61346 Bad Homburg, Germany
Financial Metrics
The provided filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K serves as a cover document to furnish a press release (Exhibit 99.1) but does not contain the financial data within the text provided.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It references a press release issued on February 21, 2020, as Exhibit 99.1, which likely contains the relevant operational or financial updates, but the content of that exhibit is not included in the input.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These elements are expected to be contained within the referenced Exhibit 99.1 press release.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Press Release issued February 21, 2020) for actual financial results or strategic announcements.
- Confirm the company's status as a Foreign Private Issuer filing under Form 20-F.
- Note that the filing was signed by Rice Powell (CEO) and Helen Giza (CFO) on behalf of the General Partner.